Brainstorm Cell Therapeutics
Stock Forecast, Prediction & Price Target
Brainstorm Cell Therapeutics Financial Estimates
Brainstorm Cell Therapeutics Revenue Estimates
Brainstorm Cell Therapeutics EBITDA Estimates
Brainstorm Cell Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $258M Low: $258M High: $258M avg. 0% | Avg: $426.89M Low: $426.89M High: $426.89M avg. 65.46% | Avg: $445.78M Low: $445.78M High: $445.78M avg. 4.42% | Avg: $136.31M Low: $136.31M High: $136.31M avg. -69.42% |
Net Income
% change YoY
| $-24.37M N/A | $-23.73M 2.63% | $-17.19M 27.55% | Avg: $-24M Low: $-10.33M High: $-10.33M avg. -39.59% | Avg: $-26.5M Low: $-10.33M High: $-10.33M avg. -10.41% | Avg: $-3.44M Low: $-3.44M High: $-3.44M avg. 86.99% | Avg: $9.90M Low: $9.90M High: $9.90M avg. 387.49% |
EBITDA
% change YoY
| $-24.27M N/A | $-24.82M -2.23% | $-16.92M 31.80% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.67 N/A | -$0.65 2.98% | -$0.4 38.46% | Avg: -$0.24 Low: -$0.24 High: -$0.24 avg. 40.00% | Avg: -$0.24 Low: -$0.24 High: -$0.24 avg. 0% | Avg: -$0.08 Low: -$0.08 High: -$0.08 avg. 66.66% | Avg: $0.23 Low: $0.23 High: $0.23 avg. 387.5% |
Operating Expenses
% change YoY
| $24.53M N/A | $24.82M 1.15% | $21.17M -14.69% | Avg: $-610.88M Low: $-610.88M High: $-610.88M avg. -2985.05% | Avg: $-1.01B Low: $-1.01B High: $-1.01B avg. -65.46% | Avg: $-1.05B Low: $-1.05B High: $-1.05B avg. -4.42% | Avg: $-322.74M Low: $-322.74M High: $-322.74M avg. 69.42% |
FAQ
What is Brainstorm Cell Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 106.11% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -10.33M, average is -24M and high is -10.33M.
What is Brainstorm Cell Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 0.11% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $258M, average is $258M and high is $258M.
What is Brainstorm Cell Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 123.54% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.24, average is -$0.24 and high is $-0.24.